Primecap Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Primecap Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-50,500	Closed	-$1.75M	–	328
2025 Q3	$1.75M	Sell	50,500 -92,810	-65%	-$2.97M	﹤0.01%	303
2025 Q2	$4.01M	Sell	143,310 -3,900	-3%	-$105K	﹤0.01%	291
2025 Q1	$3.7M	Sell	147,210 -484,000	-77%	-$12.2M	﹤0.01%	289
2024 Q4	$17.4M	Sell	631,210 -89,030	-12%	-$2.48M	0.01%	237
2024 Q3	$20.7M	Hold	720,240	–	–	0.02%	231
2024 Q2	$17.8M	Buy	720,240 +5,000	+0.7%	+$142K	0.01%	231
2024 Q1	$23M	Buy	715,240 +36,363	+5%	+$1.35M	0.02%	225
2023 Q4	$27.6M	Buy	678,877 +9,200	+1%	+$339K	0.02%	218
2023 Q3	$23.1M	Buy	669,677 +3,300	+0.5%	+$128K	0.02%	223
2023 Q2	$27.1M	Buy	666,377 +9,000	+1%	+$367K	0.02%	218
2023 Q1	$25.4M	Buy	+657,377	New	+$27M	0.02%	217

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Primecap Management's LKFT Position: Q4 2025 in Review

Primecap Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2025, closing a stake of 50,500 shares — an estimated $1.75M sold.

Primecap Management first reported a position in LKFT in Q1 2023 and held it in 11 quarters. The position peaked at $27.6M in Q4 2023. 90 funds tracked by Wall St. Rank hold LKFT as of Q4 2025.

Primecap Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2025 after selling out during the quarter.
Primecap Management sold 50,500 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2025, an estimated $1.75M.
Primecap Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2023 and held it in 11 quarters.
Primecap Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $27.6M in Q4 2023.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2025.

Based on Primecap Management's 13F filing for Q4 2025, filed 11 Feb 2026.